Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Harvard Business School
Moodys
Dow
Baxter

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

TESSALON Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Tessalon, and when can generic versions of Tessalon launch?

Tessalon is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in TESSALON is benzonatate. There are six drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the benzonatate profile page.

US ANDA Litigation and Generic Entry Outlook for Tessalon

A generic version of TESSALON was approved as benzonatate by BIONPHARMA INC on January 28th, 2020.

  Start Trial

Drug patent expirations by year for TESSALON
Drug Prices for TESSALON

See drug prices for TESSALON

Pharmacology for TESSALON
Synonyms for TESSALON
104-31-4
2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-(butylamino)benzoate
2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl 4-butylaminobenzoate
2-[2-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl-4-butylaminobenzoate
2,5,8,11,14,17,20,23,26-nonaoxaoctacosan-28-yl 4-(butylamino)benzoate
2,5,8,11,14,17,20,23,26-Nonaoxaoctacosan-28-yl p-(butylamino)benzoate
3,6,9,12,15,18,21,24,27-Nonaoxaoctacos-1-yl 4-(butylamino)benzoate
3,6,9,12,15,18,21,24,27-Nonaoxaoctacos-1-yl 4-(butylamino)benzoate #
3,6,9,12,15,18,21,24,27-nonaoxaoctacosyl 4-butylaminobenzoate
3,6,9,12,15,18,21,24,27-Nonaoxaoctacosyl-4-butylaminobenzoate;3,6,9,12,15,18,21,24,27-Nonaoxaoctacosyl-4-butylaminobenzoate
4-(butylamino)benzoic acid 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester
4-(butylamino)benzoicacid3,6,9,12,15,18,21,24,27-nonaoxao-ctacos-1-ylester
5P4DHS6ENR
AB00513795
AB00513795_06
AC1L1PCL
AC1Q68HL
AKOS015891366
BC222308
benzoate Benzonatato
Benzoic acid, 4-(butylamino)-, 2,5,8,11,14,17,20,23,26-nonaoxaoctacos-28-yl ester
Benzoic acid, 4-(butylamino)-, 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester
Benzoic acid, p-(butylamino)-, 2-(2-(2-(2-(2-(2-(2-(2-(2-methoxyethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethoxy)ethyl ester
Benzoic acid,4-(butylamino)-, 3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yl ester
benzoicacid,4-(butylamino)-,3,6,9,12,15,18,21,24,27-nonaoxaoctacos-1-yles
Benzonatat
Benzonatate
Benzonatate (USP/INN)
Benzonatate [USAN:INN:BAN]
Benzonatate [USP:INN:BAN]
Benzonatato
Benzonatato [INN-Spanish]
Benzonatatum
Benzonatatum [INN-Latin]
Benzononantin
Benzononatine
BPBio1_000049
BSPBio_000043
C30H53NO11
CAS-104-31-4
CCG-213706
CHEBI:3032
CHEMBL1374379
CTK8F7974
D00242
DB00868
DSSTox_CID_2655
DSSTox_GSID_22655
DSSTox_RID_76676
DTXSID9022655
EINECS 203-194-7
Exangit
FT-0622718
GTPL7611
HMS1568C05
HMS2095C05
HMS2230M19
HMS3373I11
HMS3712C05
HSDB 7933
I01-9684
J-001145
KM-65
KM65
LS-36322
MAFMQEKGGFWBAB-UHFFFAOYSA-N
MLS002154171
NCGC00016362-01
NCGC00016362-02
NCGC00016362-03
NCGC00016362-05
nonaethyleneglycol monomethyl ether p-n-butylaminobenzoate
Nonaethyleneglycol-p-n-butylaminobenzoate methyl ester
NSC-760128
NSC760128
p-(butylamino)-benzoicaci2-(2-(2-(2-(2-(2-(2-(2-(2-methoxyethoxy)ethoxy)e
p-(n)-Butylaminobenzoesaeure-(nonaaethylenglykol-monomethylaether)-ester
p-(n)-Butylaminobenzoesaeure-(nonaaethylenglykol-monomethylaether)-ester [German]
p-butylaminobenzoic acid omega-O-methylnonaethyleneglycol ester
Pharmakon1600-01503864
Polyethyleneglycol-p-n-butylaminobenzoate methyl ester
Prestwick0_000012
Prestwick1_000012
Prestwick2_000012
Prestwick3_000012
SCHEMBL28366
SMR001233469
SPBio_001964
SR-01000841197
SR-01000841197-2
Tesalon
Tessalin
Tessalon Perles
Tessalon perles (TN)
Tessalon-ciba
Tox21_110398
Tox21_110398_1
UNII-5P4DHS6ENR
Ventussin
Ventussin-loz
ZINC3830276
Zonatuss

US Patents and Regulatory Information for TESSALON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer TESSALON benzonatate CAPSULE;ORAL 011210-001 Approved Prior to Jan 1, 1982 AA RX Yes No   Start Trial   Start Trial   Start Trial
Pfizer TESSALON benzonatate CAPSULE;ORAL 011210-003 Jun 25, 1999 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
McKinsey
Express Scripts
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.